Trades on 1 secondary market
Qlaris Bio
Qlaris Bio is a clinical-stage biotechnology company focused on developing first-in-class therapies for ophthalmic diseases, with a mission to preserve vision and prevent blindness. Its lead candidate, QLS-111, uses a novel mechanism of action to lower intraocular pressure by targeting the distal ou
Qlaris Bio is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.